Syneos Health, Inc., a contract research organization, provides various clinical development services for the medical device and biopharmaceutical industries in North America, Europe, the Middle East and Africa, Asia-Pacific, and Latin America. The company is headquartered in Raleigh, North Carolina.
| Revenue (TTM) | $243.12M |
| Gross Profit (TTM) | $40.61M |
| EBITDA | $-8.36M |
| Operating Margin | 0.00% |
| Return on Equity | -9.27% |
| Return on Assets | -2.19% |
| Revenue/Share (TTM) | $4.83 |
| Book Value | $7.59 |
| Price-to-Book | 0.33 |
| Price-to-Sales (TTM) | 0.54 |
| EV/Revenue | 1.116 |
| EV/EBITDA | 5.29 |
| Quarterly Earnings Growth (YoY) | -84.70% |
| Quarterly Revenue Growth (YoY) | 23.90% |
| Shares Outstanding | $54.68M |
| Float | $35.19M |
| % Insiders | 26.05% |
| % Institutions | 1.14% |
Volatility is currently expanding